Oxygenta (OXYGENTAPH) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
1.1B
Gross Profit
16.7M
1.53%
Operating Income
-117.3M
-10.73%
Net Income
-103.0M
-9.42%
Balance Sheet Metrics
Total Assets
828.0M
Total Liabilities
1.1B
Shareholders Equity
-256.4M
Cash Flow Metrics
Operating Cash Flow
-89.0M
Free Cash Flow
-87.9M
Revenue & Profitability Trend
Oxygenta Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 396.4M | 309.9M | 605.2M | 520.3M |
| Cost of Goods Sold | 1.1B | 409.9M | 305.8M | 565.7M | 423.0M |
| Gross Profit | 16.7M | -13.5M | 4.1M | 39.6M | 97.3M |
| Operating Expenses | 47.1M | 21.9M | 14.7M | 16.9M | 16.2M |
| Operating Income | -117.3M | -123.7M | -91.5M | -1.2M | 26.5M |
| Pre-tax Income | -143.5M | -138.7M | -113.7M | -4.9M | 31.4M |
| Income Tax | -40.5M | -103.9M | 2.0M | 1.2M | 2.1M |
| Net Income | -103.0M | -34.8M | -115.7M | -6.1M | 29.3M |
| EPS (Diluted) | - | -₹1.09 | -₹8.15 | -₹0.48 | ₹2.87 |
Income Statement Trend
Oxygenta Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 309.4M | 241.1M | 250.1M | 95.6M | 159.4M |
| Non-Current Assets | 518.6M | 390.9M | 292.6M | 216.1M | 179.2M |
| Total Assets | 828.0M | 631.9M | 542.6M | 311.8M | 338.6M |
| Liabilities | |||||
| Current Liabilities | 858.5M | 337.0M | 329.0M | 80.7M | 175.0M |
| Non-Current Liabilities | 226.0M | 496.2M | 675.7M | 577.4M | 543.9M |
| Total Liabilities | 1.1B | 833.1M | 1.0B | 658.1M | 718.8M |
| Equity | |||||
| Total Shareholders Equity | -256.4M | -201.2M | -462.0M | -346.3M | -380.2M |
Balance Sheet Composition
Oxygenta Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -143.5M | -138.7M | -113.7M | -4.9M | 31.4M |
| Operating Cash Flow | -89.0M | -118.5M | -248.9M | 58.2M | -108.6M |
| Investing Activities | |||||
| Capital Expenditures | -112.7M | -41.1M | -96.4M | -49.5M | -67.4M |
| Investing Cash Flow | -112.7M | -41.1M | -96.4M | -49.5M | -67.4M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 379.3M | 294.9M | -1.0K | 40.0M | 0 |
| Free Cash Flow | -87.9M | -171.6M | -112.8M | -66.3M | -83.6M |
Cash Flow Trend
Oxygenta Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
444.32
Price to Sales
4.10
Profitability Ratios
Profit Margin
-9.42%
Operating Margin
-2.93%
Return on Equity
40.16%
Return on Assets
-10.04%
Financial Health
Current Ratio
0.36
Debt to Equity
-2.43
Beta
0.44
Per Share Data
EPS (TTM)
-₹2.86
Book Value per Share
-₹7.15
Revenue per Share
₹30.35
Financial data is updated regularly. All figures are in the company's reporting currency.